CURIS, INC. Shareholders' Equity
CURIS, INC. (CRIS) had Shareholders' Equity of $4.70 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.70M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $12.71M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.46M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$14.69M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $4.70M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $12.71M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $5.46M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$14.69M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$13.99M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$6.61M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$6.00M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$8.73M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$694.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $9.46M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $19.67M 10-K · filed 2026-03-24 | |
| 2023-09-30 | $29.59M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $26.23M 10-Q · filed 2024-11-14 | $26.22M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $36.59M 10-Q · filed 2024-11-14 | $36.59M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $46.55M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $55.74M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $62.05M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $75.97M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $90.71M 10-K · filed 2024-02-08 | |
| 2021-09-30 | $102.91M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $112.47M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $121.92M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $130.67M 10-K · filed 2023-03-13 | |
| 2020-09-30 | -$28.61M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$30.38M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | -$40.27M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | -$33.91M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$26.02M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$20.27M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | -$13.73M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | -$4.50M 10-K · filed 2022-02-24 | |
| 2018-09-30 | $782.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $7.11M 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $14.47M 10-Q · filed 2019-11-05 | $14.47M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $23.99M 10-K · filed 2020-03-19 | |
| 2017-09-30 | $30.45M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $9.23M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $21.48M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $29.45M 10-K · filed 2019-03-26 | $29.27M 10-K · filed 2017-03-09 |
| 2016-09-30 | $37.87M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $46.19M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $55.94M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $64.51M 10-K · filed 2018-03-08 | $64.51M 10-K · filed 2016-02-29 |
| 2015-09-30 | $75.99M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $80.58M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $87.62M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $29.78M 10-K · filed 2018-03-08 | $29.78M 10-K · filed 2015-02-24 |
| 2014-09-30 | $34.65M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $39.41M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $40.54M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $45.17M 10-K · filed 2017-03-09 | $45.17M 10-K · filed 2014-03-13 |
| 2013-09-30 | $41.57M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $32.76M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $30.25M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $34.27M 10-K · filed 2016-02-29 | |
| 2012-09-30 | $45.72M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $47.05M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $47.60M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $39.88M 10-K · filed 2015-02-24 | |
| 2011-09-30 | $32.41M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $36.13M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $45.52M 10-K · filed 2014-03-13 | |
| 2009-12-31 | $33.05M 10-K · filed 2013-03-13 | |
| 2008-12-31 | $37.22M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |